In our quest to confront and overcome some of the most pressing health care challenges, we anticipate an increasingly complex health care landscape. Over the near term, we envision a number of challenges, 6 of which we find most relevant to healthcare executives: increasing disease burden, health care system pressures, decentralized care delivery, early detection, monitoring and intervention, access to health care and transformative technologies.

Like you, these challenges have a significant impact on our decision making. They shape the choices that we make as we embark on our ambition to confront and overcome some of the most pressing health care challenges and deliver 20 transformative medicines addressing diseases with the highest societal burden by 2030.

A cancer screening awareness campaign focused on Black and Latina women, created “by the community, for the community.” We collaborated with local health systems and community organizations from across New York City to launch Love Letters for Cancer Screening, a multicultural initiative.

Its goal is to reduce inequities in care, using the power of love to spread messages about the importance of cancer screening for women. Love Letters for Cancer Screening was also launched in partnership with Cancer Screen Week partners, the American Cancer Society, Optum and StandUptoCancer.

Genentech shares your commitment to advancing patient care and reducing barriers to treatment. From product information and patient access to screening initiatives, Genentech provides resources to help you and your patients, whether your focus is getting one patient on a Genentech therapy or on improving the entire patient population.

Our resources may be able to help health care providers, administrators and/or practice staff assist patients after a Genentech medicine has been prescribed.